Sloan Sheldon
Insider CIK 2038798 · SYRE Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SYRE Spyre Therapeutics, Inc. | M Exercise deriv | 2026-07-01 | 2026-07-02 | 8,334 | — | $0 | 305,000 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | M Exercise | 2026-07-01 | 2026-07-02 | 8,334 | $27.46 | $228.9K | 8,334 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-07-01 | 2026-07-02 | 6,500 | $87.52 | $568.9K | 1,834 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-07-01 | 2026-07-02 | 1,834 | $88.34 | $162.0K | 0 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | M Exercise deriv | 2026-06-03 | 2026-06-03 | 8,333 | — | $0 | 313,334 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-06-03 | 2026-06-03 | 8,333 | $75.00 | $625.0K | 0 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | M Exercise | 2026-06-03 | 2026-06-03 | 8,333 | $27.46 | $228.8K | 8,333 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | M Exercise deriv | 2026-05-01 | 2026-05-01 | 78,333 | — | $0 | 321,667 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-05-01 | 2026-05-01 | 21,306 | $69.53 | $1.48M | 57,027 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-05-01 | 2026-05-01 | 400 | $75.37 | $30.1K | 0 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-05-01 | 2026-05-01 | 19,656 | $70.61 | $1.39M | 37,371 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-05-01 | 2026-05-01 | 8,777 | $71.56 | $628.1K | 28,594 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-05-01 | 2026-05-01 | 12,777 | $72.94 | $932.0K | 15,817 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-05-01 | 2026-05-01 | 10,358 | $73.74 | $763.8K | 5,459 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-05-01 | 2026-05-01 | 5,059 | $74.60 | $377.4K | 400 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | M Exercise | 2026-05-01 | 2026-05-01 | 78,333 | $27.46 | $2.15M | 78,333 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | M Exercise deriv | 2026-04-01 | 2026-04-03 | 7,958 | — | $0 | 87,542 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | M Exercise | 2026-04-01 | 2026-04-03 | 7,958 | $21.66 | $172.4K | 7,958 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-04-01 | 2026-04-03 | 7,958 | $50.00 | $397.9K | 0 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | A Award deriv | 2026-01-09 | 2026-01-13 | 140,000 | — | $0 | 140,000 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | A Award deriv | 2025-01-15 | 2025-01-17 | 95,500 | — | $0 | 95,500 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | A Award deriv | 2024-10-01 | 2024-10-01 | 400,000 | — | $0 | 400,000 | SEC↗ |